[{"Year":"2007","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":94.1},{"Year":"2008","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":95.3},{"Year":"2009","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":95.4},{"Year":"2010","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":96.5},{"Year":"2011","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":95.1},{"Year":"2012","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":96.2},{"Year":"2013","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":96.9},{"Year":"2014","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":95.8},{"Year":"2015","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":96.6},{"Year":"2016","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":96.1},{"Year":"2017","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":93.4},{"Year":"2018","Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Value":94.5},{"Year":"2007","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":98.8},{"Year":"2008","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":99.1},{"Year":"2009","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":98.9},{"Year":"2010","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":98.3},{"Year":"2011","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":97.2},{"Year":"2012","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":97.7},{"Year":"2013","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":98.666102},{"Year":"2014","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":95.6},{"Year":"2015","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":99.1},{"Year":"2016","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":97.0},{"Year":"2017","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":94.7},{"Year":"2018","Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Value":96.244215},{"Year":"2015","Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)","Value":96.8},{"Year":"2016","Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)","Value":97.2},{"Year":"2017","Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)","Value":94.2},{"Year":"2018","Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)","Value":92.0}]